Literature DB >> 25400757

B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.

Min Fan1, Qianfeng Zhuang1, Yiming Chen1, Tao Ding1, Hongwei Yao1, Lujun Chen2, Xiaozhou He1, Xianlin Xu1.   

Abstract

OBJECTIVE: To investigate the mRNA and protein levels of B7-H4, a B7 family molecule, in human urothelial cell carcinoma (UCC), to analyze the relationship between B7-H4 protein expression level and pathological stage of UCC, and to examine the potential of B7-H4 as a prognostic factor in UCC.
METHODS: mRNA and protein levels of B7-H4 were measured in pairs of tumor tissues and matched adjacent nontumor tissue obtained from patients with UCC by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemical staining, respectively. Association of the protein level of B7-H4 with pathological tumor stage and the overall survival of UCC patients were also analyzed.
RESULTS: B7-H4 mRNA and protein level were significantly higher in UCC tumor tissues compared with adjacent nontumor tissues as assessed by qRT-PCR and immunohistochemical staining, respectively. Higher B7-H4 protein levels were observed in patients with more advanced pathological stage of UCC and were also associated with decreased overall survival of patients with UCC.
CONCLUSIONS: The findings from this study indicate that B7-H4 has the potential to be an independent prognostic indicator for UCC.

Entities:  

Keywords:  B7 family; B7-H4; Bladder cancer; gene expression; prognosis

Mesh:

Substances:

Year:  2014        PMID: 25400757      PMCID: PMC4230072     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.

Authors:  In-Hak Choi; Gefeng Zhu; Gabriel L Sica; Scott E Strome; John C Cheville; Julie S Lau; Yuwen Zhu; Dallas B Flies; Koji Tamada; Lieping Chen
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 2.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.

Authors:  Amy E Krambeck; R Houston Thompson; Haidong Dong; Christine M Lohse; Eugene S Park; Susan M Kuntz; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

4.  A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder.

Authors:  J W Slaton; D A Swanson; H B Grossman; C P Dinney
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

5.  B7-H4 overexpression in ovarian tumors.

Authors:  Barbara Tringler; Wenhui Liu; Laura Corral; Kathleen C Torkko; Takayuki Enomoto; Susan Davidson; M Scott Lucia; David E Heinz; Jackie Papkoff; Kenneth R Shroyer
Journal:  Gynecol Oncol       Date:  2005-10-26       Impact factor: 5.482

Review 6.  [Urinary bladder tumours. The new 2004 WHO classification].

Authors:  M Seitz; D Zaak; R Knüchel-Clarke; C Stief
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

7.  B7-H3 and B7-H4 expression in non-small-cell lung cancer.

Authors:  Yuping Sun; Yunshan Wang; Jianqiang Zhao; Ming Gu; Ricardo Giscombe; Ann Kari Lefvert; Xiongbiao Wang
Journal:  Lung Cancer       Date:  2006-06-19       Impact factor: 5.705

8.  Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.

Authors:  Craig G Rogers; Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Yair Lotan; Amit Gupta; Amnon Vazina; Amiel Gilad; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

9.  The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.

Authors:  Susana Salceda; Tenny Tang; Muriel Kmet; Andrei Munteanu; Malavika Ghosh; Roberto Macina; Wenhui Liu; Glenn Pilkington; Jackie Papkoff
Journal:  Exp Cell Res       Date:  2005-05-15       Impact factor: 3.905

10.  The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

Authors:  E J Bromwich; P A McArdle; K Canna; D C McMillan; A-M McNicol; M Brown; M Aitchison
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  11 in total

Review 1.  The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.

Authors:  Alexander Sankin; Deepa Narasimhulu; Peter John; Benjamin Gartrell; Mark Schoenberg; Xingxing Zang
Journal:  Urol Oncol       Date:  2017-05-08       Impact factor: 3.498

Review 2.  Immunotherapy in endometrial cancer: rationale, practice and perspectives.

Authors:  Wenyu Cao; Xinyue Ma; Jean Victoria Fischer; Chenggong Sun; Beihua Kong; Qing Zhang
Journal:  Biomark Res       Date:  2021-06-16

Review 3.  The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial.

Authors:  Peter John; Yao Wei; Weifeng Liu; Meirong Du; Fangxia Guan; Xingxing Zang
Journal:  Trends Pharmacol Sci       Date:  2019-10-31       Impact factor: 14.819

4.  B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.

Authors:  Qiang Dong; Xinlong Ma
Journal:  Biomed Res Int       Date:  2015-04-14       Impact factor: 3.411

Review 5.  Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?

Authors:  Alessandra Modena; Chiara Ciccarese; Roberto Iacovelli; Matteo Brunelli; Rodolfo Montironi; Michelangelo Fiorentino; Giampaolo Tortora; Francesco Massari
Journal:  Oncol Rev       Date:  2016-04-15

6.  Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.

Authors:  Xing Song; Yingjie Shao; Wendong Gu; Chao Xu; Huihui Mao; Honglei Pei; Jingting Jiang
Journal:  Oncotarget       Date:  2016-11-22

7.  Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.

Authors:  Lujun Chen; Quanqin Xie; Zhigang Wang; Liangrong Shi; Changping Wu; Jingting Jiang
Journal:  Oncotarget       Date:  2016-11-22

8.  Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model.

Authors:  Damini Chand; Deepika Dhawan; Alexander Sankin; Xiaoxin Ren; Juan Lin; Mark Schoenberg; Deborah W Knapp; Xingxing Zang
Journal:  Bladder Cancer       Date:  2019-01-31

Review 9.  B7x-from bench to bedside.

Authors:  Gurbakhash Kaur; Murali Janakiram
Journal:  ESMO Open       Date:  2019-09-08

10.  B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis.

Authors:  Zibo Meng; Feiyang Wang; Yushun Zhang; Shoukang Li; Heshui Wu
Journal:  Oncotarget       Date:  2017-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.